Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast tablets in Chinese patients with severe COPD
CTR20160254Phase 2Suspended
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Aug 2016; status: suspended.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20160254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160254.